about
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptorEffect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia.Suboptimal management of severe menopausal symptoms by Nigerian Gynaecologists: a call for mandatory continuing medical education for physicians.Current and potential future drug treatments for osteoporosis.An analysis of breast cancer coverage in selected women's magazines, 1987-1995.Raloxifene, a new selective estrogen receptor modulator.Identification of the novel player deltaEF1 in estrogen transcriptional cascades.Premature ovarian failure: etiology and prospects.Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.A naturally occurring naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblastsDifferential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies.Hormone replacement therapy for all? Universal prescription is desirableRole of phytoestrogens in cancer therapy.The Effect of Pueraria Lobata/Rehmannia Glutinosa and Exercise on Fatty Acid Transporters Expression in Ovariectomized Rats Skeletal MusclesEffect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding.Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.Equilenin-2'-deoxynucleoside adducts: analysis with nano-liquid chromatography coupled to nano-electrospray tandem mass spectrometry.Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry.Phytoestrogenic isoflavones daidzein and genistein reduce glucose-toxicity-induced cardiac contractile dysfunction in ventricular myocytes.Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.Acute hazards to young children from residential pesticide exposures.
P2860
Q24616079-73987EDA-EEF6-4729-9AED-8C1FB0D798ADQ33181873-2F02167F-F9CD-4F30-8D4B-EBA2ABA41561Q33512107-76A12321-FD0C-4344-AFC6-0ACEF251A48BQ33579316-D2342F26-0270-4DD9-AF23-0DFAF5EC5C7BQ33648470-F9F2596E-0C29-4F39-B0F9-55F062AE3354Q33703846-0E043C2E-66C6-4F1D-B59C-C4D4BCE113D2Q33957974-623E89F7-2171-45D0-8471-6A3070E2491EQ34081134-86151933-CB68-4DA0-872C-63A4C2FF0704Q34470807-224A9FB1-02B0-402F-A690-3937C6928F15Q35803706-0A933A61-FCBC-4F5B-B47B-7DBD4CA17445Q36024969-27CC138A-33B0-4D2B-9919-CBC6D79D8F3AQ36052802-D9F2F8A7-0274-4BC6-992A-8606E10FDEC5Q36271670-8EEA0EE1-C87D-428B-B2BA-E2D142380EDAQ36599598-AB2973AF-B9B5-4B20-8A4F-70C36D1CDFA3Q37238391-A64F0D0D-B408-46FF-B805-90D7BE7D2EF3Q37345182-2A42A237-D7C8-44A7-9269-987349F5B702Q39408981-7D69854A-C899-4D73-B786-4DD7241257E1Q39607279-796E61E7-E3FA-4A64-B012-64F1C0065033Q43581844-300556CF-298D-4DDB-9C7D-0DA2E25527B4Q44439828-BBF0A8E4-3E4C-46D3-A9F3-1115F085ABC9Q45097315-2B30A7FC-15CD-4D76-B027-9C1776F65B96Q51737037-B77B1EC7-06D7-44B4-AF4C-EB97DF429D73Q54048930-181AA40D-9D74-4F04-9313-B04A71F69B0A
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Benefits and risks of estrogen replacement therapy.
@en
type
label
Benefits and risks of estrogen replacement therapy.
@en
prefLabel
Benefits and risks of estrogen replacement therapy.
@en
P1476
Benefits and risks of estrogen replacement therapy.
@en
P2093
P304
P356
10.1016/0002-9378(95)90247-3
P407
P433
P577
1995-09-01T00:00:00Z